VERV REMINDER – Robbins LLP Urges VERV Investors to Obtain Legal Counsel in Light of the Pending Lead Plaintiff Deadline
04. Oktober 2024 20:40 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
VERV CLASS ACTION: Verve Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit
17. September 2024 18:31 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
VERV Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Verve Therapeutics, Inc. Class Action
04. September 2024 18:36 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial
Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against Verve Therapeutics, Inc.
28. August 2024 17:09 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Verve Therapeutics, Inc. (VERV) Misled Investors Regarding its Clinical Trial